ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma

Liu, Jun; Lu, Jianjun; Li, Wenli*南方医科大学; 汕头大学; 中山大学; 1
2021-6-3DOI: 10.1155/2021/5546032
8被引5阅读
引用收藏
分享

摘要

There are few reports on the role of genes associated with the mRNA expression-based sternness index (mRNAsi) in the prognosis and immune regulation of hepatocellular carcinoma (HCC). This study is aimed at analyzing the expression profile and prognostic significance of a new mRNAsi-based three-gene signature in HCC. This three-gene signature was identified by analyzing mRNAsi data from the Cancer Genome Atlas (TCGA) HCC dataset. The prognostic value of the risk score based on the three-gene signature was evaluated by Cox regression and Kaplan-Meier analysis and then verified in the International Cancer Genome Consortium (ICGC) database. Meanwhile, the correlations between the risk score and immune cell infiltration patterns, microsatellite instability (MSI), tumor mutation burden (TMB), immune checkpoint molecules, hypoxia-related genes, immunotherapy response, and compounds targeting the gene signature were explored, respectively. The results showed that compared with normal liver tissues, the mRNAsi score of HCC tissues was significantly increased. PTDSS2, MRPL9, and SOCS were the genes most related to mRNAsi in HCC tissues. Survival analysis results suggested the risk score based on the three-gene signature was an independent predictor of the prognosis for patients with HCC. The nomogram combining the risk score and pathological stage showed a good predictive ability for the overall survival of patients with HCC patients. Meanwhile, the risk score was significantly related to immune cell infiltration patterns, MSI, TMB, several immune checkpoint molecules, and hypoxia-related genes. In addition, the risk score was associated with the immunotherapy response, and fifteen potential therapeutic drugs targeting the three-gene signature were identified. Therefore, we propose to use this three-gene signature including PTDSS2, MRPL9, and SOCS as a potential prognostic biomarker for HCC.

学科与关键词

关键词
CANCER STEM-CELLSPOOR-PROGNOSISSELF-RENEWALEXPRESSIONSURVIVALRECURRENCEBIOLOGYCD133
相关
加载中…
  • Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma.
    Li, Yue; He, Xiaoqin; Zhang, Xiaoyu; Xu, Yangtao; Wu, Yaogui*; Xu, Ximing*Life Sciences, 2021, 265: 118799.
  • Risk Signature Related to Immunotherapy Reaction of Hepatocellular Carcinoma Based on the Immune-Related Genes Associated With CD8+ T Cell Infiltration
    Zou, Yiping; Chen, Zhihong; Han, Hongwei; Ruan, Shiye; Jin, Liang; Zhang, Yuanpeng; Chen, Zhengrong; Ma, Zuyi; Lou, Qi; Shi, Ning*; Jin, Haosheng*Frontiers in Molecular Biosciences, 2021, 8: 602227.被引 3
  • Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor
    Chen, Hao; Wang, Jinghua; Zeng, Ruijie; Luo, Yujun; Guo, Kehang; Wu, Huihuan; Yang, Qi; Jiang, Rui; Sha, Weihong*; Zhuo, Zewei*Journal of Oncology, 2021, 2021: 5070099.被引 6
查看全部 →

发表信息

论文状态
公开发表
发表日期
2021-06-03
卷期
第 2021 卷
页码
5546032
DOI
10.1155/2021/5546032
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE

作者

  • L

    Liu, Jun (第一作者)

    shantou univ

  • L

    Lu, Jianjun

    2 · southern med univ · 1 · sun yat sen univ

查看全部 3 位作者收起作者
  • L

    Li, Wenli (通讯)

    shantou univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417